肝动脉化疗栓塞及无水酒精注射联用治疗中晚期肝癌

目的 比较中晚期肝癌单纯肝动脉化疗栓塞（ＴＡＣＥ）及加用经皮局部无水酒精注射（ＰＥＩ）的临床疗效。方法 回顾性分析了１９９２年１月至１９９７年３月不能一期手术切除的中晚期肝癌病人１９３例，其中行ＴＡＣＥ１１５例，ＴＡＣＥ并Ｂ超引导下ＰＥＩ７８例。结果 两组近期有效率（ＷＨＯ标准）分别为１２．２％和２５．６％；治疗后获得手术切除者两者分别有４．３％和１４．１％；半年、１年和２年生存率ＴＡＣＥ组盒为６

TREATMENT OF ADVANCED LIVER CANCER BY TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION AND PERCUTANEOUS ETHANOL INJECTION

Objective To compare the clinical efficacy between transcatheter arterial chemoembolization(TACE)and TACE+percutaneous ethanol injection(PEI)in advanced liver cancer.Method During Jan,1992-Mar.1997,193 patients with unresectable advanced liver cancer were retrospectively studied.115 cases were received TACE,78 cases were treated by TACE +PEI by B-US guidance.Results The effectual rate (WHO standard)of TACE or TACE+PEI was 12.2% or 25.6% respectively.After the therapy with TACE or TACE+PEI,the secondary resectable rate was 4.3% or 14.1%.The half year,1year and 2year survial rate in TACE group was 69.6%,42.5%,and 25.5% respectively,and that in TACE+PEI group was 85.9%,61.5%,and 41.0% respectively.The effect in TACE+PEI group was significant better than that in TACE group.There were no significant differences between two group in complications.Conclusion Treating advanced liver cancer with PEI by B-US guidance is a convenient and safe means.It can improve the effect of TACE by a combined method including extending survival experiod and improving the resectable opportunity.